Zusammenfassung der Ressource
Respiratory Treatments
- Types of Rhinitis
- Non-Allergic Rhinitis
- Allergic Rhinitis
- Infective Rhinitis
- Rhinitis Medicamentosa
- Asthma
- Preventers
- Corticosteroids
- MOA: Reduce Airway Inflammation
Anmerkungen:
- MOA: Reduce Air Inflammation by inhibiting infiltration of inflammatory cells and decrease oedema by an action on vascular endothelium.
- Medication
- Beclometasone
- Budesonide
- Fluticasone
- Mometasone
- Prednisolone
Anmerkungen:
- ORAL: Morning dose to mimic circadian rhythm, for 3 to 5 days.
- Minimizing Adverse Effects
- Candidiasis
Anmerkungen:
- Use spacer, or rinse mouth (feed infants) after inhaler use. If facemask used, wipe face & apply emollient. Regular new toothbrush.
- Cataracts
Anmerkungen:
- Minimize by applying good seal around inhaler or mask, and use 'lowest effective dose' (LED)
- Indigestion, Peptic Ulceration
Anmerkungen:
- Give tablets with breakfast or morning milk
- Adrenal suppression
Anmerkungen:
- May occur >1.6mg beclometasone equivalent: Use LED.
- Cushing Syndrome
Anmerkungen:
- Osteoporosis
Anmerkungen:
- Provide calcium supplements
- Interactions
- Increase Effects
- Ciclosporin
Anmerkungen:
- Decrease Effect
- Anticonvulsants
Anmerkungen:
- Antidiabetics
Anmerkungen:
- Antihypertensives
Anmerkungen:
- Diuretics
Anmerkungen:
- Vaccines
Anmerkungen:
- Anticoagulants
- May enhance or reduce
- Leukotriene Receptor Antagonists
(LRA)
- MOA: Block cysteinyl
leukotrienes (CysLT1) in airways
Anmerkungen:
- Leukotrienes D4 (LTD4), LTC4 and LTE4 are potent bronchoconstrictors that contribute to early phase bronchospasm and late phase inflammation
- Medications
- Montelukast
- Zafirlukast
- ADRs
- GI common
- Headache
- Hyperkinesia
(in children)
- Hypersensitivity
Reactions
- Relievers - Bronchodilators
- Short-Acting B2 Agonist
- Salbutamol
- COPD